Your session is about to expire
← Back to Search
Procedure
Robotic assisted bronchoscopy for Lung Cancer (TARGET Trial)
N/A
Waitlist Available
Led By Septimiu Murgu, MD
Research Sponsored by Auris Health, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 24 months post procedure
Awards & highlights
Summary
This study is designed to evaluate clinical safety and diagnostic accuracy of the robotic-assisted bronchoscopy with biopsy performed with the Monarch™ Endoscopy Platform in a broad range of patients with pulmonary lesions.
Eligible Conditions
- Lung Cancer
- Pulmonary Nodules
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 24 months post procedure
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 24 months post procedure
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Incidence of device or procedure related complications
Secondary outcome measures
Diagnostic yield
Rate of device or procedure related complications
Stage at diagnosis
Trial Design
1Treatment groups
Experimental Treatment
Group I: Robotic assisted bronchoscopyExperimental Treatment1 Intervention
Robotic assisted bronchoscopy procedures will be performed using the Monarch platform.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Robotic assisted bronchoscopy
2018
N/A
~750
Find a Location
Who is running the clinical trial?
Auris Health, Inc.Lead Sponsor
5 Previous Clinical Trials
134 Total Patients Enrolled
Septimiu Murgu, MDPrincipal InvestigatorUniversity of Chicago
Share this study with friends
Copy Link
Messenger